The dose-response association between wearables-quantified incidental physical activity and type 2 diabetes: a prospective cohort study
Clicks: 11
ID: 329668
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
3.0
/100
11 views
10 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #285 of 407 articles by views in the journal of clinical endocrinology & metabolism
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 407 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Aim This prospective cohort study aimed to quantify dose–response associations between intensity-specific incidental physical activity (IPA) and the incidence of type 2 diabetes (T2D) in a large cohort of UK adults. A secondary aim was to estimate the T2D-specific equivalence of 1 minute of vigorous-intensity IPA relative to moderate- and light-intensity IPA. Methods Participants were adults from the UK Biobank accelerometry sub-study who self-reported as nonexercisers. Individuals were excluded if they had T2D at baseline, were using insulin therapy, or received a T2D diagnosis within 12 months of follow-up. T2D status was primarily derived from primary care records. Device-measured IPA was categorized into light (LIPA; 1.5 to <3 METs), moderate (MIPA; 3 to <6 METs), and vigorous (VIPA; ≥6 METs) intensities. Additional analyses examined the T2D-specific equivalence of 1 minute of VIPA to MIPA and LIPA. The reference group comprised participants accumulating neither MIPA nor VIPA. Results The primary analysis included 22 857 nonexercisers (mean age 62.1 ± 7.7 years, 42.8% male). Over a 7.8-year follow-up period, 721 (3.2%) participants developed T2D. MIPA and VIPA, but not LIPA, exhibited near-linear inverse associations with T2D risk. Median VIPA (4.75 minutes/day) was associated with a hazard ratio (HR) 0.62 [95% confidence interval (CI) 0.53-0.73], and median MIPA (23.70 minutes/day) showed a HR of 0.67 (95% CI: 0.52-0.86). One minute of VIPA/day was associated with an equivalent T2D risk reduction of 5.9 minutes MIPA/day and 46.6 minutes LIPA/day. Conclusion MIPA and VIPA were associated with lower T2D risk in a dose-dependent manner. Although median LIPA was linked to reduced risk, it did not demonstrate a consistent dose–response relationship.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (110 words).
Try re-searching for a better abstract.
| Reference Key |
openalex_W7214185529
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Angelo Sabag, Raaj Kishore Biswas, Nicholas A. Koemel, Monique E. François, Shelley Elizabeth Keating, Martin J. Gibala, Jonathan P. Little, Nathan Anthony Johnson, Emmanuel Stamatakis, Matthew N. Ahmadi |
| Journal | the journal of clinical endocrinology & metabolism |
| Year | 2026 |
| DOI |
10.1210/clinem/dgag316
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.